Smaroula Dilioglou, Ph.D., D(ABHI)
Associate Medical Director, Histocompatibility and Transplant Immunology
Department of Pathology and Genomic Medicine
The Methodist Hospital Physician Organization
Houston Methodist Research Institute
Assistant Professor of Pathology and Laboratory Medicine
Weill Cornell Medical College of Cornell University
6565 Fannin Street, Suite M227
Houston, Texas 77030
Dr. Dilioglou received her Ph.D. in immunology from the University of Mississippi Medical Center in Jackson, Mississippi in 2002. After completing her postdoctoral training at the St. Jude’s Children’s Research Hospital in Memphis, Tennessee, Dr. Dilioglou remained at St. Jude´s and worked in the HLA Laboratory. While there, she also worked as an independent CHT contractor at the Mid-South Transplant Foundation. At the University of Mississippi Medical Center in 2002, Dr. Dilioglou received the Robert A. Mafrey Jr. Memorial Award for Research Potential in Immunology. She assumed her current positions at Houston Methodist Hospital and Research Institute in 2007.
Representative Recent Publications
- DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA. De novo donor specific antibodies and patient outcomes in renal transplantation. Clin Transpl. 2011:351-8.
- Raghavan R, Jeroudi A, Achkar K, Suki W, Gaber AO, Knight R, Land G, Dilioglou S, Patel S, Abdellatif A. Bortezomib in kidney transplant desensitization: a case report. Clin Transpl. 2009:339-42.
- Szymczak AL, Workman CJ, Gil D, Dilioglou S, Vignali KM, Palmer E, Vignali DA. The CD3epsilon proline-rich sequence, and its interaction with Nck, is not required for T cell development and function. J Immunol. 2005 Jul 1;175(1):270-5.